Sodium‐Glucose Cotransporter‐2 Inhibitor Prevents Stroke in Patients With Diabetes and Atrial Fibrillation

BACKGROUND: Atrial fibrillation (AF) is associated with increasing risk of thromboembolic or ischemic stroke. The CHA(2)DS(2)‐VASc score is a well‐established predictor of AF stroke. Patients with AF have an increased risk of stroke if they have diabetes. Use of sodium‐glucose cotransporter‐2 inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Sheng‐Nan, Chen, Jien‐Jiun, Huang, Pang‐Shuo, Wu, Cho‐Kai, Wang, Yi‐Chih, Hwang, Juey‐Jen, Tsai, Chia‐Ti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227316/
https://www.ncbi.nlm.nih.gov/pubmed/37183872
http://dx.doi.org/10.1161/JAHA.122.027764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227316/
https://www.ncbi.nlm.nih.gov/pubmed/37183872
http://dx.doi.org/10.1161/JAHA.122.027764

Ejemplares similares